Chad E. Miller

Combination Therapy with Oral Treprostinil for Pulmonary Arterial Hypertension. A Double-Blind Placebo-controlled Clinical Trial

R. James White, Carlos Jerjes‐Sánchez, G. Meyer et al. · American Journal of Respiratory and Critical Care Medicine · 2019 · 142 citations · Full text

Psychometric Validation of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT) Questionnaire

Kelly Chin, Mardi Gomberg‐Maitland, Richard N. Channick et al. · CHEST Journal · 2018 · 58 citations · Full text

Safety and tolerability of transition from inhaled treprostinil to oral selexipag in pulmonary arterial hypertension: Results from the TRANSIT-1 study

Adaani Frost, Munir Janmohamed, Jason S. Fritz et al. · The Journal of Heart and Lung Transplantation · 2018 · 33 citations · Full text

Safety of macitentan for the treatment of pulmonary hypertension: Real‐world experience from the OPsumit® USers Registry (OPUS) and OPsumit® Historical USers cohort (OrPHeUS)

Vallerie V. McLaughlin, Richard N. Channick, Nick H. Kim et al. · Pulmonary Circulation · 2022 · 20 citations · Full text

Implementing the EXPEDITE parenteral induction protocol: Rapid parenteral treprostinil titration and transition to oral treprostinil

J.F. Kingrey, Chad E. Miller, Verónica Franco et al. · Pulmonary Circulation · 2023 · 10 citations · Full text